Clinical Trials in New York

Showing 7201-7220 of 22,668 trials

Multicenter Evaluation of Near Vision and Outdoor Time in Kids Study

NCT06119243

Currently, optical and pharmacological interventions have been developed to prevent the progression of childhood myopia. However, no myopia control strategy has been shown to have complete efficacy in controlling myopia progression in children. One possible reason is that risk factors contributing to the development of myopia were not controlled in previous clinical studies including time outdoors and near vision behaviour. This study aims to quantify time spent outdoors and near vision behavior in myopic children and its impact on myopia control efficacy. The outcomes of this study will guide clinicians on risk management and improve responses to existing treatments for progressive myopia.

Myopia

The University of New South Wales230 participantsStarted Mar 2023

Berkeley, California, United States • Boston, Massachusetts, United States • New York, New York, United States +2 more locations

TERMINATEDPhase 2< 1 mile

Erlotinib Versus Oral Etoposide in Patients With Recurrent or Refractory Pediatric Ependymoma

NCT01032070

This is a phase 2 study to evaluate the efficacy of single-agent erlotinib versus oral etoposide in patients with recurrent or refractory pediatric ependymoma.

Recurrent or Refractory Pediatric Ependymoma

OSI Pharmaceuticals25 participantsStarted Sep 2010

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Orange, California, United States +25 more locations

Multicenter Evaluation of Near Vision and Outdoor Time in Kids Study

Erlotinib Versus Oral Etoposide in Patients With Recurrent or Refractory Pediatric Ependymoma

Find Trials by Condition in New York

Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)

Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL)

A Comparative Study to Evaluate a Novel Algorithm As a Diagnostic Aid for ADHD in Youth Ages 6-17.

Comprehensive Outcomes for After Cancer Health

A Study of Bispecific Antibody MCLA-145 in Patients With Advanced or Metastatic Malignancies

IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy

Motion Syros: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness

SpineJack System Postmarket Registry

Multicultural Healthy Diet to Reduce Cognitive Decline

Ph 2 Trial of Vitamin C & G-FLIP (Low Doses Gemcitabine, 5FU, Leucovorin, Irinotecan, Oxaliplatin) for Pancreatic Cancer

A Study Evaluating Gene Therapy With BB305 Lentiviral Vector in Sickle Cell Disease

Safety and Efficacy Study of IMSA101 in Refractory Malignancies

realMIND: Observational Study on Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in Patients With Relapsed or Refractory DLBCL

A Phase III Trial of e-TNS for the Acute Treatment of Migraine

Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi

Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy

De-Implementation of Unnecessary Surgical Antibiotic Prophylaxis in Children

A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 and MAS825 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Clonal Hematopoiesis of Indeterminate Potential (CHIP)